News in brief

Nutrasource gets Health Canada approval for cannabis research license

By Stephen Daniells

- Last updated on GMT

© Nastco / Getty Images
© Nastco / Getty Images

Related tags Cannabis Clinical trials

Guelph-based Nutrasource Pharmaceutical and Nutraceutical Services has received approval for an official Institution-Wide Cannabis Research License, paving the way for human research on cannabis and cannabis-derived compounds.

The approval, granted recently by Health Canada, will give Nutrasource’s clients an accelerated path to cannabis human research authorizations. Historically, that process could be uncertain and prolong timelines when submitting individual projects on a stand-alone basis.

“This license is pivotal for our client base given that regulatory approval delays in this product category have been unpredictable, which adds substantially to the client’s project timelines and cost,” ​said William Rowe, President and CEO of Nutrasource.

This Institution-wide Cannabis Research License allows Nutrasource to:

- Expedite government approvals that will allow all human research to be conducted at the Nutrasource site without applying for multiple licenses each time a study is conducted;

- Run multiple research projects at the same site for various clients simultaneously; and

- Conduct studies (clinical and efficacy trials, sensory, pharmacokinetic, pharmacodynamic and palatability studies) that would include participants.

Joshua Baisley, VP of Clinical Trial Design & Delivery, added: “As leaders in providing clinical trial services to the global cannabis industry, this institution-wide license adds additional benefit to the favorable Canadian regulatory environment, including (CTA) Clinical Trial Applications for human studies in this expansive product category.”

Related news

Related products

show more

Consumers' growing demand for Omegas

Consumers' growing demand for Omegas

Content provided by Fruit d'Or | 13-Feb-2024 | White Paper

Consumers are increasingly interested in the benefits of omegas supplements. According to forecasts for 2023–2030, the global omega-3 market is expected...

Curcumin may support cognitive, brain & mood benefits

Curcumin may support cognitive, brain & mood benefits

Content provided by Verdure Sciences | 02-Feb-2024 | White Paper

Cognitive health, mental acuity and brain support categories have seen tremendous growth. With an aging population and increased interest from formulators...

Pomella® Extract: Prebiotic Potential in New Study

Pomella® Extract: Prebiotic Potential in New Study

Content provided by Verdure Sciences | 09-Jan-2024 | White Paper

A new clinical trial evaluated 250mg/day Pomella® for beneficial effects on the gut microbiome, circulating short chain fatty acids, and gut-microbial...

Related suppliers

Follow us


View more